{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T09:27:17Z","timestamp":1786786037234,"version":"build-2736575974"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:00:00Z","timestamp":1786752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:00:00Z","timestamp":1786752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"DOI":"10.1007\/s10555-026-10369-4","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T08:43:08Z","timestamp":1786783388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["N-Acetyltransferase 10 (NAT10) at the crossroads of metabolism, immunology, and cancer biology"],"prefix":"10.1007","volume":"45","author":[{"given":"Peng","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4077-453X","authenticated-orcid":false,"given":"Qin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,15]]},"reference":[{"issue":"5","key":"10369_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: The next generation. Cell, 144(5), 646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"issue":"15","key":"10369_CR2","doi-asserted-by":"publisher","first-page":"8556","DOI":"10.1093\/nar\/gkab626","volume":"49","author":"Y Liang","year":"2021","unstructured":"Liang, Y., Lu, Q., Li, W., Zhang, D., Zhang, F., Zou, Q., et al. (2021). Reactivation of tumour suppressor in breast cancer by enhancer switching through NamiRNA network. Nucleic Acids Research, 49(15), 8556\u20138572. https:\/\/doi.org\/10.1093\/nar\/gkab626","journal-title":"Nucleic Acids Research"},{"key":"10369_CR3","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.semcancer.2018.09.004","volume":"83","author":"Y Liang","year":"2022","unstructured":"Liang, Y., Xu, P., Zou, Q., Luo, H., & Yu, W. (2022). An epigenetic perspective on tumorigenesis: Loss of cell identity, enhancer switching, and NamiRNA network. Seminars in Cancer Biology, 83, 596\u2013604. https:\/\/doi.org\/10.1016\/j.semcancer.2018.09.004","journal-title":"Seminars in Cancer Biology"},{"issue":"17","key":"10369_CR4","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1042\/BCJ20210084","volume":"478","author":"JF Chen","year":"2021","unstructured":"Chen, J. F., & Yan, Q. (2021). The roles of epigenetics in cancer progression and metastasis. Biochemical Journal, 478(17), 3373\u20133393. https:\/\/doi.org\/10.1042\/BCJ20210084","journal-title":"Biochemical Journal"},{"issue":"1","key":"10369_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.Cd-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. (2022). Hallmarks of cancer: New dimensions. Cancer Discovery, 12(1), 31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.Cd-21-1059","journal-title":"Cancer Discovery"},{"issue":"2","key":"10369_CR6","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.bbrc.2003.09.235","volume":"311","author":"J Lv","year":"2003","unstructured":"Lv, J., Liu, H., Wang, Q., Tang, Z., Hou, L., & Zhang, B. (2003). Molecular cloning of a novel human gene encoding histone acetyltransferase-like protein involved in transcriptional activation of hTERT. Biochemical and Biophysical Research Communications, 311(2), 506\u2013513. https:\/\/doi.org\/10.1016\/j.bbrc.2003.09.235","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"37","key":"10369_CR7","doi-asserted-by":"publisher","first-page":"27447","DOI":"10.1074\/jbc.M703098200","volume":"282","author":"YH Chi","year":"2007","unstructured":"Chi, Y. H., Haller, K., Peloponese, J. M., Jr., & Jeang, K. T. (2007). Histone acetyltransferase hALP and nuclear membrane protein hsSUN1 function in de-condensation of mitotic chromosomes. Journal of Biological Chemistry, 282(37), 27447\u201327458. https:\/\/doi.org\/10.1074\/jbc.M703098200","journal-title":"Journal of Biological Chemistry"},{"issue":"10","key":"10369_CR8","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/j.yexcr.2009.03.007","volume":"315","author":"Q Shen","year":"2009","unstructured":"Shen, Q., Zheng, X., McNutt, M. A., Guang, L., Sun, Y., Wang, J., et al. (2009). NAT10, a nucleolar protein, localizes to the midbody and regulates cytokinesis and acetylation of microtubules. Experimental Cell Research, 315(10), 1653\u20131667. https:\/\/doi.org\/10.1016\/j.yexcr.2009.03.007","journal-title":"Experimental Cell Research"},{"issue":"4","key":"10369_CR9","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/s41418-021-00899-5","volume":"29","author":"J Zheng","year":"2022","unstructured":"Zheng, J., Tan, Y., Liu, X., Zhang, C., Su, K., Jiang, Y., et al. (2022). NAT10 regulates mitotic cell fate by acetylating Eg5 to control bipolar spindle assembly and chromosome segregation. Cell Death & Differentiation, 29(4), 846\u2013860. https:\/\/doi.org\/10.1038\/s41418-021-00899-5","journal-title":"Cell Death & Differentiation"},{"key":"10369_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115628","volume":"213","author":"J Luo","year":"2023","unstructured":"Luo, J., Cao, J., Chen, C., & Xie, H. (2023). Emerging role of RNA acetylation modification ac4C in diseases: Current advances and future challenges. Biochemical Pharmacology, 213, Article 115628. https:\/\/doi.org\/10.1016\/j.bcp.2023.115628","journal-title":"Biochemical Pharmacology"},{"issue":"15","key":"10369_CR11","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1038\/s41388-024-02975-9","volume":"43","author":"MH Dalhat","year":"2024","unstructured":"Dalhat, M. H., Narayan, S., Serio, H., & Arango, D. (2024). Dissecting the oncogenic properties of essential RNA-modifying enzymes: A focus on NAT10. Oncogene, 43(15), 1077\u20131086. https:\/\/doi.org\/10.1038\/s41388-024-02975-9","journal-title":"Oncogene"},{"key":"10369_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.gde.2024.102207","volume":"87","author":"C Achour","year":"2024","unstructured":"Achour, C., & Oberdoerffer, S. (2024). NAT10 and cytidine acetylation in mRNA: Intersecting paths in development and disease. Current Opinion in Genetics & Development, 87, Article 102207. https:\/\/doi.org\/10.1016\/j.gde.2024.102207","journal-title":"Current Opinion in Genetics & Development"},{"issue":"6","key":"10369_CR13","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.bpj.2024.02.007","volume":"123","author":"DA Ramirez","year":"2024","unstructured":"Ramirez, D. A., Hough, L. E., & Shirts, M. R. (2024). Coiled-coil domains are sufficient to drive liquid-liquid phase separation in protein models. Biophysical Journal, 123(6), 703\u2013717. https:\/\/doi.org\/10.1016\/j.bpj.2024.02.007","journal-title":"Biophysical Journal"},{"issue":"19","key":"10369_CR14","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1158\/0008-5472.Can-23-4062","volume":"84","author":"S Liu","year":"2024","unstructured":"Liu, S., Lin, C., Lin, X., Lin, P., He, R., Pan, X., et al. (2024). NAT10 phase separation regulates YTHDF1 splicing to promote gastric cancer progression. Cancer Research, 84(19), 3207\u20133222. https:\/\/doi.org\/10.1158\/0008-5472.Can-23-4062","journal-title":"Cancer Research"},{"issue":"9","key":"10369_CR15","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1038\/emboj.2009.69","volume":"28","author":"S Chimnaronk","year":"2009","unstructured":"Chimnaronk, S., Suzuki, T., Manita, T., Ikeuchi, Y., Yao, M., Suzuki, T., et al. (2009). RNA helicase module in an acetyltransferase that modifies a specific tRNA anticodon. The EMBO Journal, 28(9), 1362\u20131373. https:\/\/doi.org\/10.1038\/emboj.2009.69","journal-title":"The EMBO Journal"},{"key":"10369_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-74222-6","author":"M Zhou","year":"2026","unstructured":"Zhou, M., Thalalla Gamage, S., Tran, K. A., Bartee, D., Wei, X., Yin, B., et al. (2026). Structure of the NAT10 acetyltransferase and mechanism of tRNA acetylation. Nature Communications. https:\/\/doi.org\/10.1038\/s41467-026-74222-6","journal-title":"Nature Communications"},{"key":"10369_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2025.101241","volume":"81","author":"Z Xu","year":"2025","unstructured":"Xu, Z., Zhu, M., Geng, L., Zhang, J., Xia, J., Wang, Q., et al. (2025). Targeting NAT10 attenuates homologous recombination via destabilizing DNA: RNA hybrids and overcomes PARP inhibitor resistance in cancers. Drug Resistance Updates, 81, Article 101241. https:\/\/doi.org\/10.1016\/j.drup.2025.101241","journal-title":"Drug Resistance Updates"},{"issue":"24","key":"10369_CR18","doi-asserted-by":"publisher","first-page":"4526","DOI":"10.1016\/j.molcel.2025.11.010","volume":"85","author":"R Amin","year":"2025","unstructured":"Amin, R., Ha, N. H., Qiu, T., Holewinski, R., Lam, K. C., Daugherty-Lop\u00e8s, A., et al. (2025). NAT10 promotes cancer metastasis by modulating p300\/CBP activity through chromatin-associated tRNA. Molecular Cell, 85(24), 4526\u20134544.e4518. https:\/\/doi.org\/10.1016\/j.molcel.2025.11.010","journal-title":"Molecular Cell"},{"issue":"3","key":"10369_CR19","doi-asserted-by":"publisher","first-page":"349","DOI":"10.15252\/embr.201540505","volume":"17","author":"X Liu","year":"2016","unstructured":"Liu, X., Tan, Y., Zhang, C., Zhang, Y., Zhang, L., Ren, P., et al. (2016). NAT10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2. The EMBO Reports, 17(3), 349\u2013366. https:\/\/doi.org\/10.15252\/embr.201540505","journal-title":"The EMBO Reports"},{"issue":"7","key":"10369_CR20","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1016\/j.celrep.2019.10.028","volume":"29","author":"T Wang","year":"2019","unstructured":"Wang, T., Zou, Y., Huang, N., Teng, J., & Chen, J. (2019). CCDC84 acetylation oscillation regulates centrosome duplication by modulating HsSAS-6 degradation. Cell Reports, 29(7), 2078\u20132091.e2075. https:\/\/doi.org\/10.1016\/j.celrep.2019.10.028","journal-title":"Cell Reports"},{"issue":"16","key":"10369_CR21","doi-asserted-by":"publisher","first-page":"8502","DOI":"10.1093\/nar\/gkz545","volume":"47","author":"L Zhang","year":"2019","unstructured":"Zhang, L., & Li, D. Q. (2019). MORC2 regulates DNA damage response through a PARP1-dependent pathway. Nucleic Acids Research, 47(16), 8502\u20138520. https:\/\/doi.org\/10.1093\/nar\/gkz545","journal-title":"Nucleic Acids Research"},{"issue":"7","key":"10369_CR22","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1093\/nar\/gkaa130","volume":"48","author":"HY Liu","year":"2020","unstructured":"Liu, H. Y., Liu, Y. Y., Yang, F., Zhang, L., Zhang, F. L., Hu, X., et al. (2020). Acetylation of MORC2 by NAT10 regulates cell-cycle checkpoint control and resistance to DNA-damaging chemotherapy and radiotherapy in breast cancer. Nucleic Acids Research, 48(7), 3638\u20133656. https:\/\/doi.org\/10.1093\/nar\/gkaa130","journal-title":"Nucleic Acids Research"},{"key":"10369_CR23","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41419-024-06951-9","volume":"15","author":"Y Wang","year":"2024","unstructured":"Wang, Y., Su, K., Wang, C., Deng, T., Liu, X., Sun, S., et al. (2024). Chemotherapy-induced acetylation of ACLY by NAT10 promotes its nuclear accumulation and acetyl-CoA production to drive chemoresistance in hepatocellular carcinoma. Cell Death Dis, 15(7), 545.\u00a0https:\/\/doi.org\/10.1038\/s41419-024-06951-9","journal-title":"Cell Death and Disease"},{"issue":"1","key":"10369_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12964-022-00932-1","volume":"20","author":"HY Liu","year":"2022","unstructured":"Liu, H. Y., Liu, Y. Y., Zhang, Y. L., Ning, Y., Zhang, F. L., & Li, D. Q. (2022). Poly(ADP-ribosyl)ation of acetyltransferase NAT10 by PARP1 is required for its nucleoplasmic translocation and function in response to DNA damage. Cell Communication and Signaling: CCS, 20(1), 127. https:\/\/doi.org\/10.1186\/s12964-022-00932-1","journal-title":"Cell Communication and Signaling: CCS"},{"key":"10369_CR25","doi-asserted-by":"publisher","DOI":"10.1242\/dev.200231","author":"MM Shan","year":"2022","unstructured":"Shan, M. M., Zou, Y. J., Pan, Z. N., Zhang, H. L., Xu, Y., Ju, J. Q., et al. (2022). Kinesin motor KIFC1 is required for tubulin acetylation and actin-dependent spindle migration in mouse oocyte meiosis. Development. https:\/\/doi.org\/10.1242\/dev.200231","journal-title":"Development"},{"issue":"8","key":"10369_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-022-04447-3","volume":"79","author":"YJ Zou","year":"2022","unstructured":"Zou, Y. J., Shan, M. M., Wan, X., Liu, J. C., Zhang, K. H., Ju, J. Q., et al. (2022). Kinesin KIF15 regulates tubulin acetylation and spindle assembly checkpoint in mouse oocyte meiosis. Cellular and Molecular Life Sciences, 79(8), Article 422. https:\/\/doi.org\/10.1007\/s00018-022-04447-3","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"1","key":"10369_CR27","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1186\/s12964-024-01869-3","volume":"22","author":"K Su","year":"2024","unstructured":"Su, K., Zhao, Z., Wang, Y., Sun, S., Liu, X., Zhang, C., et al. (2024). NAT10 resolves harmful nucleolar R-loops depending on its helicase domain and acetylation of DDX21. Cell Communication and Signaling: CCS, 22(1), 490. https:\/\/doi.org\/10.1186\/s12964-024-01869-3","journal-title":"Cell Communication and Signaling: CCS"},{"issue":"1","key":"10369_CR28","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.bbrc.2016.12.092","volume":"483","author":"S Cai","year":"2017","unstructured":"Cai, S., Liu, X., Zhang, C., Xing, B., & Du, X. (2017). Autoacetylation of NAT10 is critical for its function in rRNA transcription activation. Biochemical and Biophysical Research Communications, 483(1), 624\u2013629. https:\/\/doi.org\/10.1016\/j.bbrc.2016.12.092","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"4","key":"10369_CR29","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1093\/nar\/gkv075","volume":"43","author":"S Sharma","year":"2015","unstructured":"Sharma, S., Langhendries, J. L., Watzinger, P., K\u00f6tter, P., Entian, K. D., & Lafontaine, D. L. (2015). Yeast Kre33 and human NAT10 are conserved 18S rRNA cytosine acetyltransferases that modify tRNAs assisted by the adaptor Tan1\/THUMPD1. Nucleic Acids Research, 43(4), 2242\u20132258. https:\/\/doi.org\/10.1093\/nar\/gkv075","journal-title":"Nucleic Acids Research"},{"issue":"52","key":"10369_CR30","doi-asserted-by":"publisher","first-page":"35724","DOI":"10.1074\/jbc.C114.602698","volume":"289","author":"S Ito","year":"2014","unstructured":"Ito, S., Horikawa, S., Suzuki, T., Kawauchi, H., Tanaka, Y., & Suzuki, T. (2014). Human NAT10 is an ATP-dependent RNA acetyltransferase responsible for N4-acetylcytidine formation in 18 S ribosomal RNA (rRNA). Journal of Biological Chemistry, 289(52), 35724\u201335730. https:\/\/doi.org\/10.1074\/jbc.C114.602698","journal-title":"Journal of Biological Chemistry"},{"issue":"12","key":"10369_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ads2923","volume":"11","author":"S Thalalla Gamage","year":"2025","unstructured":"Thalalla Gamage, S., Khoogar, R., Howpay Manage, S., DaRos, J. T., Crawford, M. C., Georgeson, J., et al. (2025). Transfer RNA acetylation regulates in vivo mammalian stress signaling. Science Advances, 11(12), Article eads2923. https:\/\/doi.org\/10.1126\/sciadv.ads2923","journal-title":"Science Advances"},{"issue":"38","key":"10369_CR32","doi-asserted-by":"publisher","first-page":"26201","DOI":"10.1074\/jbc.M114.593996","volume":"289","author":"S Ito","year":"2014","unstructured":"Ito, S., Akamatsu, Y., Noma, A., Kimura, S., Miyauchi, K., Ikeuchi, Y., et al. (2014). A single acetylation of 18 S rRNA is essential for biogenesis of the small ribosomal subunit in Saccharomyces cerevisiae. Journal of Biological Chemistry, 289(38), 26201\u201326212. https:\/\/doi.org\/10.1074\/jbc.M114.593996","journal-title":"Journal of Biological Chemistry"},{"issue":"7","key":"10369_CR33","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/j.cell.2018.10.030","volume":"175","author":"D Arango","year":"2018","unstructured":"Arango, D., Sturgill, D., Alhusaini, N., Dillman, A. A., Sweet, T. J., Hanson, G., et al. (2018). Acetylation of cytidine in mRNA promotes translation efficiency. Cell, 175(7), 1872\u20131886.e1824. https:\/\/doi.org\/10.1016\/j.cell.2018.10.030","journal-title":"Cell"},{"issue":"15","key":"10369_CR34","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1016\/j.molcel.2022.05.016","volume":"82","author":"D Arango","year":"2022","unstructured":"Arango, D., Sturgill, D., Yang, R., Kanai, T., Bauer, P., Roy, J., et al. (2022). Direct epitranscriptomic regulation of mammalian translation initiation through N4-acetylcytidine. Molecular Cell, 82(15), 2797\u20132814.e2711. https:\/\/doi.org\/10.1016\/j.molcel.2022.05.016","journal-title":"Molecular Cell"},{"issue":"7817","key":"10369_CR35","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41586-020-2418-2","volume":"583","author":"A Sas-Chen","year":"2020","unstructured":"Sas-Chen, A., Thomas, J. M., Matzov, D., Taoka, M., Nance, K. D., Nir, R., et al. (2020). Dynamic RNA acetylation revealed by quantitative cross-evolutionary mapping. Nature, 583(7817), 638\u2013643. https:\/\/doi.org\/10.1038\/s41586-020-2418-2","journal-title":"Nature"},{"issue":"8","key":"10369_CR36","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/j.molcel.2024.03.017","volume":"84","author":"J Georgeson","year":"2024","unstructured":"Georgeson, J., & Schwartz, S. (2024). No evidence for ac4C within human mRNA upon data reassessment. Molecular Cell, 84(8), 1601\u20131610.e1602. https:\/\/doi.org\/10.1016\/j.molcel.2024.03.017","journal-title":"Molecular Cell"},{"issue":"8","key":"10369_CR37","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.molcel.2024.03.018","volume":"84","author":"H Beiki","year":"2024","unstructured":"Beiki, H., Sturgill, D., Arango, D., Relier, S., Schiffers, S., & Oberdoerffer, S. (2024). Detection of ac4C in human mRNA is preserved upon data reassessment. Molecular Cell, 84(8), 1611\u20131625.e1613. https:\/\/doi.org\/10.1016\/j.molcel.2024.03.018","journal-title":"Molecular Cell"},{"issue":"2","key":"10369_CR38","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.chom.2020.05.011","volume":"28","author":"K Tsai","year":"2020","unstructured":"Tsai, K., Jaguva Vasudevan, A. A., Martinez Campos, C., Emery, A., Swanstrom, R., & Cullen, B. R. (2020). Acetylation of cytidine residues boosts HIV-1 gene expression by increasing viral RNA stability. Cell Host & Microbe, 28(2), 306\u2013312.e306. https:\/\/doi.org\/10.1016\/j.chom.2020.05.011","journal-title":"Cell Host & Microbe"},{"issue":"16","key":"10369_CR39","doi-asserted-by":"publisher","first-page":"9339","DOI":"10.1093\/nar\/gkac675","volume":"50","author":"H Hao","year":"2022","unstructured":"Hao, H., Liu, W., Miao, Y., Ma, L., Yu, B., Liu, L., et al. (2022). N4-acetylcytidine regulates the replication and pathogenicity of enterovirus 71. Nucleic Acids Research, 50(16), 9339\u20139354. https:\/\/doi.org\/10.1093\/nar\/gkac675","journal-title":"Nucleic Acids Research"},{"issue":"1","key":"10369_CR40","doi-asserted-by":"publisher","first-page":"6327","DOI":"10.1038\/s41467-023-42135-3","volume":"14","author":"Q Yan","year":"2023","unstructured":"Yan, Q., Zhou, J., Wang, Z., Ding, X., Ma, X., Li, W., et al. (2023). NAT10-dependent N(4)-acetylcytidine modification mediates PAN RNA stability, KSHV reactivation, and IFI16-related inflammasome activation. Nature Communications, 14(1), 6327. https:\/\/doi.org\/10.1038\/s41467-023-42135-3","journal-title":"Nature Communications"},{"issue":"11","key":"10369_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.105307","volume":"299","author":"S Yang","year":"2023","unstructured":"Yang, S., Winstone, L., Mondal, S., & Wu, Y. (2023). Helicases in R-loop formation and resolution. Journal of Biological Chemistry, 299(11), Article 105307. https:\/\/doi.org\/10.1016\/j.jbc.2023.105307","journal-title":"Journal of Biological Chemistry"},{"issue":"13","key":"10369_CR42","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ads6144","volume":"11","author":"TK Debnath","year":"2025","unstructured":"Debnath, T. K., Abell, N. S., Li, Y. R., Devanathan, S. K., Navedo, E., & Xhemal\u00e7e, B. (2025). NAT10 and N(4)-acetylcytidine restrain R-loop levels and related inflammatory responses. Science Advances, 11(13), Article eads6144. https:\/\/doi.org\/10.1126\/sciadv.ads6144","journal-title":"Science Advances"},{"issue":"6","key":"10369_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2026.117408","volume":"45","author":"X Wu","year":"2026","unstructured":"Wu, X., Wang, D., Taori, S., Wu, W., Dixit, D., Lv, D., et al. (2026). NAT10-dependent N(4)-acetylcytidine reprograms R-loops and promotes cancer stem cell growth. Cell Reports, 45(6), Article 117408. https:\/\/doi.org\/10.1016\/j.celrep.2026.117408","journal-title":"Cell Reports"},{"issue":"47","key":"10369_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202400133","volume":"11","author":"ZY Jiang","year":"2024","unstructured":"Jiang, Z. Y., Wu, Y. K., Deng, Z. Q., Chen, L., Zhu, Y. M., Yu, Y. S., et al. (2024). PCBP1\/2 and TDP43 function as NAT10 adaptors to mediate mRNA ac(4)C formation in mammalian cells. Advanced Science, 11(47), Article e2400133. https:\/\/doi.org\/10.1002\/advs.202400133","journal-title":"Advanced Science"},{"issue":"13","key":"10369_CR45","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ads6021","volume":"11","author":"JF Chen","year":"2025","unstructured":"Chen, J. F., Xu, P., Cai, W. L., Chen, H., Wingrove, E., Shi, X., et al. (2025). An in vivo screen identifies NAT10 as a master regulator of brain metastasis. Science Advances, 11(13), Article eads6021. https:\/\/doi.org\/10.1126\/sciadv.ads6021","journal-title":"Science Advances"},{"issue":"6","key":"10369_CR46","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41556-026-01949-1","volume":"28","author":"W Li","year":"2026","unstructured":"Li, W., Huo, Y., Zhang, Z., Liu, Y., Qian, X., Ouyang, J., et al. (2026). NAT10 maintains stem cell homeostasis by mitigating mRNA decay through an ac(4)C-independent mechanism. Nature Cell Biology, 28(6), 1141\u20131154. https:\/\/doi.org\/10.1038\/s41556-026-01949-1","journal-title":"Nature Cell Biology"},{"issue":"6183","key":"10369_CR47","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1126\/science.1252651","volume":"344","author":"D Larrieu","year":"2014","unstructured":"Larrieu, D., Britton, S., Demir, M., Rodriguez, R., & Jackson, S. P. (2014). Chemical inhibition of NAT10 corrects defects of laminopathic cells. Science, 344(6183), 527\u2013532. https:\/\/doi.org\/10.1126\/science.1252651","journal-title":"Science"},{"issue":"12","key":"10369_CR48","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1038\/s41556-024-01548-y","volume":"26","author":"S Zhang","year":"2024","unstructured":"Zhang, S., Huang, F., Wang, Y., Long, Y., Li, Y., Kang, Y., et al. (2024). NAT10-mediated mRNA N(4)-acetylcytidine reprograms serine metabolism to drive leukaemogenesis and stemness in acute myeloid leukaemia. Nature Cell Biology, 26(12), 2168\u20132182. https:\/\/doi.org\/10.1038\/s41556-024-01548-y","journal-title":"Nature Cell Biology"},{"issue":"19","key":"10369_CR49","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2501185123","volume":"123","author":"WD Yang","year":"2026","unstructured":"Yang, W. D., Lu, M. R., Shen, Q., Zhou, P. H., Diao, Y., Xia, S., et al. (2026). Lactylated NAT10 contributes to elesclomol-triggered cuproptosis via the NAT10\/ac4C-DLAT-mRNA\/DLAT positive feedback loop in CRC. Proceedings of the National Academy of Sciences of the United States of America, 123(19), Article e2501185123. https:\/\/doi.org\/10.1073\/pnas.2501185123","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"10369_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.738","volume":"12","author":"G Wang","year":"2022","unstructured":"Wang, G., Zhang, M., Zhang, Y., Xie, Y., Zou, J., Zhong, J., et al. (2022). NAT10-mediated mRNA N4-acetylcytidine modification promotes bladder cancer progression. Clinical and Translational Medicine, 12(5), Article e738. https:\/\/doi.org\/10.1002\/ctm2.738","journal-title":"Clinical and Translational Medicine"},{"issue":"8","key":"10369_CR51","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1016\/j.apsb.2022.01.015","volume":"12","author":"R Wei","year":"2022","unstructured":"Wei, R., Cui, X., Min, J., Lin, Z., Zhou, Y., Guo, M., et al. (2022). NAT10 promotes cell proliferation by acetylating CEP170 mRNA to enhance translation efficiency in multiple myeloma. Acta Pharmaceutica Sinica B, 12(8), 3313\u20133325. https:\/\/doi.org\/10.1016\/j.apsb.2022.01.015","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"1","key":"10369_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-03200-x","volume":"43","author":"G Li","year":"2024","unstructured":"Li, G., Ma, X., Sui, S., Chen, Y., Li, H., Liu, L., et al. (2024). NAT10\/ac4C\/JunB facilitates TNBC malignant progression and immunosuppression by driving glycolysis addiction. Journal of Experimental & Clinical Cancer Research, 43(1), Article 278. https:\/\/doi.org\/10.1186\/s13046-024-03200-x","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"1","key":"10369_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02586-w","volume":"42","author":"M Deng","year":"2023","unstructured":"Deng, M., Zhang, L., Zheng, W., Chen, J., Du, N., Li, M., et al. (2023). Helicobacter pylori-induced NAT10 stabilizes MDM2 mRNA via RNA acetylation to facilitate gastric cancer progression. Journal of Experimental & Clinical Cancer Research, 42(1), Article 9. https:\/\/doi.org\/10.1186\/s13046-022-02586-w","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"11","key":"10369_CR54","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/s41419-023-06245-6","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu, Y., Wang, X., Liu, Y., Yang, J., Mao, W., Feng, C., et al. (2023). N4-acetylcytidine-dependent GLMP mRNA stabilization by NAT10 promotes head and neck squamous cell carcinoma metastasis and remodels tumor microenvironment through MAPK\/ERK signaling pathway. Cell Death & Disease, 14(11), 712. https:\/\/doi.org\/10.1038\/s41419-023-06245-6","journal-title":"Cell Death & Disease"},{"issue":"W1","key":"10369_CR55","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang, Z., Kang, B., Li, C., Chen, T., & Zhang, Z. (2019). GEPIA2: An enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Research, 47(W1), W556\u2013w560. https:\/\/doi.org\/10.1093\/nar\/gkz430","journal-title":"Nucleic Acids Research"},{"issue":"W1","key":"10369_CR56","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li, T., Fu, J., Zeng, Z., Cohen, D., Li, J., Chen, Q., et al. (2020). TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Research, 48(W1), W509\u2013w514. https:\/\/doi.org\/10.1093\/nar\/gkaa407","journal-title":"Nucleic Acids Research"},{"issue":"3","key":"10369_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2024.100625","volume":"5","author":"B Gy\u0151rffy","year":"2024","unstructured":"Gy\u0151rffy, B. (2024). Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors. Innovation (Cambridge, Mass.), 5(3), Article 100625. https:\/\/doi.org\/10.1016\/j.xinn.2024.100625","journal-title":"Innovation (Cambridge, Mass.)"},{"issue":"10","key":"10369_CR58","first-page":"4215","volume":"8","author":"R Ma","year":"2016","unstructured":"Ma, R., Chen, J., Jiang, S., Lin, S., Zhang, X., & Liang, X. (2016). Up regulation of NAT10 promotes metastasis of hepatocellular carcinoma cells through epithelial-to-mesenchymal transition. American Journal of Translational Research, 8(10), 4215\u20134223.","journal-title":"American Journal of Translational Research"},{"issue":"1","key":"10369_CR59","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41392-021-00489-4","volume":"6","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., Jing, Y., Wang, Y., Tang, J., Zhu, X., Jin, W. L., et al. (2021). NAT10 promotes gastric cancer metastasis via N4-acetylated COL5A1. Signal Transduction and Targeted Therapy, 6(1), 173. https:\/\/doi.org\/10.1038\/s41392-021-00489-4","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10369_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-023-00793-4","author":"L Liao","year":"2023","unstructured":"Liao, L., He, Y., Li, S. J., Yu, X. M., Liu, Z. C., Liang, Y. Y., et al. (2023). Lysine 2-hydroxyisobutyrylation of NAT10 promotes cancer metastasis in an ac4C-dependent manner. Cell Research. https:\/\/doi.org\/10.1038\/s41422-023-00793-4","journal-title":"Cell Research"},{"issue":"1","key":"10369_CR61","first-page":"256","volume":"10","author":"J Wu","year":"2018","unstructured":"Wu, J., Zhu, H., Wu, J., Chen, W., & Guan, X. (2018). Inhibition of N-acetyltransferase 10 using remodelin attenuates doxorubicin resistance by reversing the epithelial-mesenchymal transition in breast cancer. American Journal of Translational Research, 10(1), 256\u2013264.","journal-title":"American Journal of Translational Research"},{"issue":"7","key":"10369_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112810","volume":"42","author":"W Wei","year":"2023","unstructured":"Wei, W., Zhang, S., Han, H., Wang, X., Zheng, S., Wang, Z., et al. (2023). NAT10-mediated ac4C tRNA modification promotes EGFR mRNA translation and gefitinib resistance in cancer. Cell Reports, 42(7), Article 112810. https:\/\/doi.org\/10.1016\/j.celrep.2023.112810","journal-title":"Cell Reports"},{"key":"10369_CR63","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-22-2233","author":"R Xie","year":"2023","unstructured":"Xie, R., Cheng, L., Huang, M., Huang, L., Chen, Z., Zhang, Q., et al. (2023). NAT10 drives cisplatin chemoresistance by enhancing ac4C-associated DNA repair in bladder cancer. Cancer Research. https:\/\/doi.org\/10.1158\/0008-5472.Can-22-2233","journal-title":"Cancer Research"},{"issue":"1","key":"10369_CR64","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41420-023-01355-8","volume":"9","author":"Z Pan","year":"2023","unstructured":"Pan, Z., Bao, Y., Hu, M., Zhu, Y., Tan, C., Fan, L., et al. (2023). Role of NAT10-mediated ac4C-modified HSP90AA1 RNA acetylation in ER stress-mediated metastasis and lenvatinib resistance in hepatocellular carcinoma. Cell Death Discovery, 9(1), 56. https:\/\/doi.org\/10.1038\/s41420-023-01355-8","journal-title":"Cell Death Discovery"},{"issue":"10","key":"10369_CR65","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1111\/cas.16249","volume":"115","author":"Z Xue","year":"2024","unstructured":"Xue, Z., Xie, H., Shan, Y., Zhang, L., Cheng, L., Chen, W., et al. (2024). NAT10 inhibition promotes ac4C-dependent ferroptosis to counteract sorafenib resistance in nasopharyngeal carcinoma. Cancer Science, 115(10), 3256\u20133272. https:\/\/doi.org\/10.1111\/cas.16249","journal-title":"Cancer Science"},{"issue":"3","key":"10369_CR66","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","volume":"34","author":"NN Pavlova","year":"2022","unstructured":"Pavlova, N. N., Zhu, J., & Thompson, C. B. (2022). The hallmarks of cancer metabolism: Still emerging. Cell Metabolism, 34(3), 355\u2013377. https:\/\/doi.org\/10.1016\/j.cmet.2022.01.007","journal-title":"Cell Metabolism"},{"issue":"48","key":"10369_CR67","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1038\/s41388-024-03185-z","volume":"43","author":"Y Liu","year":"2024","unstructured":"Liu, Y., Li, J., Xu, J., Long, Y., Wang, Y., Liu, X., et al. (2024). m(6)A-driven NAT10 translation facilitates fatty acid metabolic rewiring to suppress ferroptosis and promote ovarian tumorigenesis through enhancing ACOT7 mRNA acetylation. Oncogene, 43(48), 3498\u20133516. https:\/\/doi.org\/10.1038\/s41388-024-03185-z","journal-title":"Oncogene"},{"issue":"1","key":"10369_CR68","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41419-023-06373-z","volume":"15","author":"Y Shuai","year":"2024","unstructured":"Shuai, Y., Zhang, H., Liu, C., Wang, J., Jiang, Y., Sun, J., et al. (2024). CLIC3 interacts with NAT10 to inhibit N4-acetylcytidine modification of p21 mRNA and promote bladder cancer progression. Cell Death & Disease, 15(1), 9. https:\/\/doi.org\/10.1038\/s41419-023-06373-z","journal-title":"Cell Death & Disease"},{"issue":"32","key":"10369_CR69","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202302705","volume":"10","author":"X Chen","year":"2023","unstructured":"Chen, X., Hao, Y., Liu, Y., Zhong, S., You, Y., Ao, K., et al. (2023). NAT10\/ac4C\/FOXP1 promotes malignant progression and facilitates immunosuppression by reprogramming glycolytic metabolism in cervical cancer. Adv Sci (Weinh), 10(32), Article e2302705. https:\/\/doi.org\/10.1002\/advs.202302705","journal-title":"Adv Sci (Weinh)"},{"issue":"7","key":"10369_CR70","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1747","volume":"14","author":"M Ding","year":"2024","unstructured":"Ding, M., Yu, Z., Lu, T., Hu, S., Zhou, X., & Wang, X. (2024). N-acetyltransferase 10 facilitates tumorigenesis of diffuse large B-cell lymphoma by regulating AMPK\/mTOR signalling through N4-acetylcytidine modification of SLC30A9. Clinical and Translational Medicine, 14(7), Article e1747. https:\/\/doi.org\/10.1002\/ctm2.1747","journal-title":"Clinical and Translational Medicine"},{"issue":"1","key":"10369_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02551-7","volume":"41","author":"C Jin","year":"2022","unstructured":"Jin, C., Wang, T., Zhang, D., Yang, P., Zhang, C., Peng, W., et al. (2022). Acetyltransferase NAT10 regulates the Wnt\/\u03b2-catenin signaling pathway to promote colorectal cancer progression via ac(4)C acetylation of KIF23 mRNA. Journal of Experimental & Clinical Cancer Research, 41(1), Article 345. https:\/\/doi.org\/10.1186\/s13046-022-02551-7","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"9","key":"10369_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101728","volume":"5","author":"Y Zou","year":"2024","unstructured":"Zou, Y., Guo, S., Wen, L., Lv, D., Tu, J., Liao, Y., et al. (2024). Targeting NAT10 inhibits osteosarcoma progression via ATF4\/ASNS-mediated asparagine biosynthesis. Cell Reports Medicine, 5(9), Article 101728. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101728","journal-title":"Cell Reports Medicine"},{"key":"10369_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11457","volume":"7","author":"AS Krall","year":"2016","unstructured":"Krall, A. S., Xu, S., Graeber, T. G., Braas, D., & Christofk, H. R. (2016). Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor. Nature Communications, 7, Article 11457. https:\/\/doi.org\/10.1038\/ncomms11457","journal-title":"Nature Communications"},{"issue":"7692","key":"10369_CR74","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nature25465","volume":"554","author":"SRV Knott","year":"2018","unstructured":"Knott, S. R. V., Wagenblast, E., Khan, S., Kim, S. Y., Soto, M., Wagner, M., et al. (2018). Asparagine bioavailability governs metastasis in a model of breast cancer. Nature, 554(7692), 378\u2013381. https:\/\/doi.org\/10.1038\/nature25465","journal-title":"Nature"},{"issue":"9","key":"10369_CR75","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1045","volume":"12","author":"MH Dalhat","year":"2022","unstructured":"Dalhat, M. H., Mohammed, M. R. S., Alkhatabi, H. A., Rehan, M., Ahmad, A., Choudhry, H., et al. (2022). NAT10: An RNA cytidine transferase regulates fatty acid metabolism in cancer cells. Clinical and Translational Medicine, 12(9), Article e1045. https:\/\/doi.org\/10.1002\/ctm2.1045","journal-title":"Clinical and Translational Medicine"},{"issue":"12","key":"10369_CR76","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1002\/jcb.30155","volume":"122","author":"MH Dalhat","year":"2021","unstructured":"Dalhat, M. H., Mohammed, M. R. S., Ahmad, A., Khan, M. I., & Choudhry, H. (2021). Remodelin, a N-acetyltransferase 10 (NAT10) inhibitor, alters mitochondrial lipid metabolism in cancer cells. Journal of Cellular Biochemistry, 122(12), 1936\u20131945. https:\/\/doi.org\/10.1002\/jcb.30155","journal-title":"Journal of Cellular Biochemistry"},{"issue":"12","key":"10369_CR77","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.molcel.2022.03.022","volume":"82","author":"D Liang","year":"2022","unstructured":"Liang, D., Minikes, A. M., & Jiang, X. (2022). Ferroptosis at the intersection of lipid metabolism and cellular signaling. Molecular Cell, 82(12), 2215\u20132227. https:\/\/doi.org\/10.1016\/j.molcel.2022.03.022","journal-title":"Molecular Cell"},{"issue":"12","key":"10369_CR78","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/cac2.12363","volume":"42","author":"X Zheng","year":"2022","unstructured":"Zheng, X., Wang, Q., Zhou, Y., Zhang, D., Geng, Y., Hu, W., et al. (2022). N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA. Cancer Communications (London, England), 42(12), 1347\u20131366. https:\/\/doi.org\/10.1002\/cac2.12363","journal-title":"Cancer Communications (London, England)"},{"key":"10369_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12051116","author":"MH Dalhat","year":"2023","unstructured":"Dalhat, M. H., Choudhry, H., & Khan, M. I. (2023). NAT10, an RNA cytidine acetyltransferase, regulates ferroptosis in cancer cells. Antioxidants. https:\/\/doi.org\/10.3390\/antiox12051116","journal-title":"Antioxidants"},{"issue":"23","key":"10369_CR80","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202300898","volume":"10","author":"Q Yang","year":"2023","unstructured":"Yang, Q., Lei, X., He, J., Peng, Y., Zhang, Y., Ling, R., et al. (2023). N4-Acetylcytidine drives glycolysis addiction in gastric cancer via NAT10\/SEPT9\/HIF-1\u03b1 positive feedback loop. Adv Sci (Weinh), 10(23), Article e2300898. https:\/\/doi.org\/10.1002\/advs.202300898","journal-title":"Adv Sci (Weinh)"},{"issue":"10","key":"10369_CR81","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","volume":"56","author":"I Mellman","year":"2023","unstructured":"Mellman, I., Chen, D. S., Powles, T., & Turley, S. J. (2023). The cancer-immunity cycle: Indication, genotype, and immunotype. Immunity, 56(10), 2188\u20132205. https:\/\/doi.org\/10.1016\/j.immuni.2023.09.011","journal-title":"Immunity"},{"issue":"1","key":"10369_CR82","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.31474","volume":"240","author":"Y Mo","year":"2025","unstructured":"Mo, Y., Huang, E., Deng, C., Huang, H., Zhu, Y., Wei, X., et al. (2025). NAT10 functions as a pivotal regulator in gastric cancer metastasis and tumor immunity. Journal of Cellular Physiology, 240(1), Article e31474. https:\/\/doi.org\/10.1002\/jcp.31474","journal-title":"Journal of Cellular Physiology"},{"issue":"1","key":"10369_CR83","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s43556-024-00228-5","volume":"5","author":"J Liu","year":"2024","unstructured":"Liu, J., Gu, Z., Zou, L., Zhang, Z., Shen, L., Wang, R., et al. (2024). Acetyltransferase NAT10 promotes an immunosuppressive microenvironment by modulating CD8(+) T cell activity in prostate cancer. Mol Biomed, 5(1), 67. https:\/\/doi.org\/10.1186\/s43556-024-00228-5","journal-title":"Mol Biomed"},{"issue":"1","key":"10369_CR84","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s10020-024-00780-4","volume":"30","author":"G Qin","year":"2024","unstructured":"Qin, G., Bai, F., Hu, H., Zhang, J., Zhan, W., Wu, Z., et al. (2024). Targeting the NAT10\/NPM1 axis abrogates PD-L1 expression and improves the response to immune checkpoint blockade therapy. Molecular Medicine, 30(1), 13. https:\/\/doi.org\/10.1186\/s10020-024-00780-4","journal-title":"Molecular Medicine"},{"issue":"1","key":"10369_CR85","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41420-024-01997-2","volume":"10","author":"Z Wang","year":"2024","unstructured":"Wang, Z., Luo, J., Huang, H., Wang, L., Lv, T., Wang, Z., et al. (2024). NAT10-mediated upregulation of GAS5 facilitates immune cell infiltration in non-small cell lung cancer via the MYBBP1A-p53\/IRF1\/type I interferon signaling axis. Cell Death Discov, 10(1), 240. https:\/\/doi.org\/10.1038\/s41420-024-01997-2","journal-title":"Cell Death Discov"},{"key":"10369_CR86","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202410263","author":"C Chen","year":"2025","unstructured":"Chen, C., Wang, Z., Lin, Q., Li, M., Xu, L., Fu, Y., et al. (2025). NAT10 promotes gastric cancer liver metastasis by modulation of M2 macrophage polarization and metastatic tumor cell hepatic adhesion. Advanced Science. https:\/\/doi.org\/10.1002\/advs.202410263","journal-title":"Advanced Science"},{"key":"10369_CR87","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010301","author":"H Xie","year":"2025","unstructured":"Xie, H., Zhang, K., Yin, H., Zhang, S., Pan, S., Wu, R., et al. (2025). Acetyltransferase NAT10 inhibits T-cell immunity and promotes nasopharyngeal carcinoma progression through DDX5\/HMGB1 axis. Journal for Immunotherapy of Cancer. https:\/\/doi.org\/10.1136\/jitc-2024-010301","journal-title":"Journal for Immunotherapy of Cancer"},{"issue":"1","key":"10369_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53350-x","volume":"15","author":"WP Li","year":"2024","unstructured":"Li, W. P., Mao, X. T., Xie, J. H., Li, J. Y., Liu, B. Q., Wu, L. X., et al. (2024). N-acetyltransferase 10 is implicated in the pathogenesis of cycling T cell-mediated autoimmune and inflammatory disorders in mice. Nature Communications, 15(1), Article 9388. https:\/\/doi.org\/10.1038\/s41467-024-53350-x","journal-title":"Nature Communications"},{"issue":"4","key":"10369_CR89","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41590-025-02100-2","volume":"26","author":"L Sun","year":"2025","unstructured":"Sun, L., Li, X., Xu, F., Chen, Y., Li, X., Yang, Z., et al. (2025). A critical role of N(4)-acetylation of cytidine in mRNA by NAT10 in T cell expansion and antiviral immunity. Nature Immunology, 26(4), 619\u2013634. https:\/\/doi.org\/10.1038\/s41590-025-02100-2","journal-title":"Nature Immunology"},{"issue":"1","key":"10369_CR90","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41421-025-00781-5","volume":"11","author":"H Li","year":"2025","unstructured":"Li, H., Cai, X., Xu, C., Yang, X., Song, X., Kong, Y., et al. (2025). RNA cytidine acetyltransferase NAT10 maintains T cell pathogenicity in inflammatory bowel disease. Cell Discovery, 11(1), 19. https:\/\/doi.org\/10.1038\/s41421-025-00781-5","journal-title":"Cell Discovery"},{"issue":"1","key":"10369_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-84908-0","volume":"11","author":"MH Dalhat","year":"2021","unstructured":"Dalhat, M. H., Altayb, H. N., Khan, M. I., & Choudhry, H. (2021). Structural insights of human N-acetyltransferase 10 and identification of its potential novel inhibitors. Scientific Reports, 11(1), Article 6051. https:\/\/doi.org\/10.1038\/s41598-021-84908-0","journal-title":"Scientific Reports"},{"issue":"11","key":"10369_CR92","first-page":"1842","volume":"8","author":"G Visani","year":"1994","unstructured":"Visani, G., Tosi, P., Zinzani, P. L., Manfroi, S., Ottaviani, E., Testoni, N., et al. (1994). FLAG (fludarabine + high-dose cytarabine + G-CSF): An effective and tolerable protocol for the treatment of \u201cpoor risk\u201d acute myeloid leukemias. Leukemia, 8(11), 1842\u20131846.","journal-title":"Leukemia"},{"issue":"24","key":"10369_CR93","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1056\/nejm200012143432402","volume":"343","author":"KR Rai","year":"2000","unstructured":"Rai, K. R., Peterson, B. L., Appelbaum, F. R., Kolitz, J., Elias, L., Shepherd, L., et al. (2000). Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. New England Journal of Medicine, 343(24), 1750\u20131757. https:\/\/doi.org\/10.1056\/nejm200012143432402","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10369_CR94","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1021\/acsmedchemlett.0c00193","volume":"12","author":"JH Shrimp","year":"2021","unstructured":"Shrimp, J. H., Jing, Y., Gamage, S. T., Nelson, K. M., Han, J., Bryson, K. M., et al. (2021). Remodelin is a cryptic assay interference chemotype that does not inhibit NAT10-dependent cytidine acetylation. ACS Medicinal Chemistry Letters, 12(6), 887\u2013892. https:\/\/doi.org\/10.1021\/acsmedchemlett.0c00193","journal-title":"ACS Medicinal Chemistry Letters"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-026-10369-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-026-10369-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-026-10369-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T08:43:10Z","timestamp":1786783390000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10555-026-10369-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,15]]},"references-count":94,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["10369"],"URL":"https:\/\/doi.org\/10.1007\/s10555-026-10369-4","relation":{},"ISSN":["1573-7233"],"issn-type":[{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,15]]},"assertion":[{"value":"13 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"QY has received research funding unrelated to this study from AstraZeneca Inc.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"58"}}